We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UCTT
3126
Ultra Clean Holdings
UCTT
$3.95B
$1.19M ﹤0.01%
38,234
+13,275
+53% +$370K
CLDX icon
3127
Celldex Therapeutics
CLDX
$3.28B
$1.19M ﹤0.01%
+67,792
New +$1.22M
DCH
3128
Dauch Corp
DCH
$1.51B
$1.19M ﹤0.01%
142,391
+41,872
+42% +$315K
EXEL icon
3129
CALL
Exelixis
EXEL
$13.4B
$1.19M ﹤0.01%
+59,200
New +$1.24M
SPNT icon
3130
SiriusPoint
SPNT
$2.68B
$1.19M ﹤0.01%
124,597
+19,558
+19% +$171K
BJRI icon
3131
BJ's Restaurants
BJRI
$1.48B
$1.19M ﹤0.01%
30,772
+9,777
+47% +$333K
CLB icon
3132
Core Laboratories
CLB
$521M
$1.18M ﹤0.01%
44,602
+3,624
+9% +$74K
SM icon
3133
SM Energy
SM
$6.87B
$1.18M ﹤0.01%
192,932
+162,636
+537% +$548K
KRRO icon
3134
Korro Bio
KRRO
$195M
$1.18M ﹤0.01%
+670
New +$884K
RIGL icon
3135
Rigel Pharmaceuticals
RIGL
$750M
$1.18M ﹤0.01%
33,668
-4,655
-12% -$135K
WNC icon
3136
Wabash National
WNC
$527M
$1.18M ﹤0.01%
68,366
+2,175
+3% +$35.2K
PVG
3137
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
$1.18M ﹤0.01%
102,400
-147,600
-59% -$1.78M
BWIN
3138
Baldwin Insurance Group
BWIN
$2.86B
$1.18M ﹤0.01%
+39,225
New +$1.13M
LASR icon
3139
nLIGHT
LASR
$3.17B
$1.17M ﹤0.01%
35,933
+14,429
+67% +$409K
WNS
3140
DELISTED
WNS Holdings
WNS
$1.17M ﹤0.01%
16,300
-7,600
-32% -$509K
SCS
3141
DELISTED
Steelcase
SCS
$1.17M ﹤0.01%
86,377
+26,257
+44% +$322K
BRKL
3142
DELISTED
Brookline Bancorp
BRKL
$1.17M ﹤0.01%
97,128
+22,210
+30% +$240K
TEO icon
3143
Telecom Argentina
TEO
$5.96B
$1.17M ﹤0.01%
178,441
-7,156
-4% -$52.9K
FLXN
3144
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.17M ﹤0.01%
101,452
-13,580
-12% -$158K
ALXO icon
3145
ALX Oncology
ALXO
$290M
$1.17M ﹤0.01%
+13,544
New +$815K
HA
3146
DELISTED
Hawaiian Holdings, Inc.
HA
$1.16M ﹤0.01%
65,762
+25,596
+64% +$433K
VNDA icon
3147
Vanda Pharmaceuticals
VNDA
$302M
$1.16M ﹤0.01%
88,465
-18,154
-17% -$219K
ANDE icon
3148
Andersons Inc
ANDE
$2.22B
$1.16M ﹤0.01%
47,285
+17,855
+61% +$397K
SNEX icon
3149
StoneX
SNEX
$7.94B
$1.16M ﹤0.01%
101,356
+26,851
+36% +$303K
PFC
3150
DELISTED
Premier Financial Corp. Common Stock
PFC
$1.16M ﹤0.01%
50,261
+13,905
+38% +$282K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.